Takeda successfully hosted the IBD Nexus Summit 2025 in the UAE, to commemorate a decade of transformative care for gastrointestinal disease patients
Dubai, UAE – Takeda, a global biopharmaceutical leader focused on patient care and one of the key players in the Inflammatory Bowel Disease (IBD) space, hosted the IBD Nexus Summit 2025 at
